Valera Pharmaceuticals Inc (VLRX) is a publicly traded company in the Unknown sector. Across all available filings, 25 corporate insiders have executed 233 transactions totaling $42.3M, demonstrating a bullish sentiment with $40.3M in net insider flow. The most recent transaction on Dec 20, 2019 involved a sale of 1,060,000 shares valued at $795.0K.
No significant insider buying has been recorded for VLRX in the recent period.
No significant insider selling has been recorded for VLRX in the recent period.
Based on recent SEC filings, insider sentiment for VLRX is bullish with an Insider Alignment Score of 98/100 and a net flow of $40.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Valera Pharmaceuticals Inc (VLRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 25 insiders are actively trading VLRX stock, having executed 233 transactions in the past 90 days. The most active insider is Investment Opportunities Partners Ii, L.p. Parallel (Executive), who has made 5 transactions totaling $40.0M.
Get notified when executives and directors at VLRX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 20, 2019 | Boyd Steven | Executive | Sale | 1,060,000 | $0.75 | $795.0K | Large |
| Dec 20, 2019 | Boyd Steven | Executive | Sale | 0 | $N/A | $0 | |
| May 24, 2019 | Llc Armistice Capital, | Executive | Purchase | 4,000 | $2.19 | $8.8K | |
| May 24, 2019 | Llc Armistice Capital, | Executive | Purchase | 0 | $N/A | $0 | |
| May 23, 2019 | Llc Armistice Capital, | Executive | Purchase | 20,000 | $2.28 | $45.6K | |
| May 23, 2019 | Llc Armistice Capital, | Executive | Purchase | 0 | $N/A | $0 | |
| May 21, 2019 | Llc Armistice Capital, | Executive | Purchase | 0 | $N/A | $0 | |
| May 21, 2019 | Llc Armistice Capital, | Executive | Purchase | 16,000 | $3.82 | $61.1K | |
| May 20, 2019 | Llc Armistice Capital, | Executive | Purchase | 0 | $N/A | $0 | |
| May 20, 2019 | Llc Armistice Capital, | Executive | Purchase | 2,000 | $4.24 | $8.5K | |
| May 20, 2019 | Llc Armistice Capital, | Executive | Purchase | 0 | $N/A | $0 | |
| May 20, 2019 | Llc Armistice Capital, | Executive | Purchase | 8,000 | $4.24 | $33.9K | |
| May 17, 2019 | Llc Armistice Capital, | Executive | Purchase | 200,000 | $0.23 | $46.0K | |
| May 17, 2019 | Llc Armistice Capital, | Executive | Purchase | 0 | $N/A | $0 | |
| May 10, 2019 | Llc Armistice Capital, | Executive | Purchase | 100,000 | $0.31 | $31.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 181 | $41.3M | 55.2% |
Conversion(C) | 17 | $32.2M | 43.0% |
Sale(S) | 9 | $1.0M | 1.3% |
Exercise(M) | 3 | $375.6K | 0.5% |
Award(A) | 4 | $30.2K | 0.0% |
Disposition(D) | 17 | $0 | 0.0% |
Other(J) | 2 | $0 | 0.0% |
Insiders at Valera Pharmaceuticals Inc are accumulating shares at an accelerated pace. With 25 insiders making 233 transactions totaling $41.3M in purchases versus $1.0M in sales, the net buying activity of $40.3M signals strong executive confidence. Investment Opportunities Partners Ii, L.p. Parallel (Executive) leads the buying activity with $40.0M in transactions across all time.